NCT07671313Not yet recruiting
Online Pain Education for Crohn's Disease and Ulcerative Colitis
Randomized Controlled Trial of Online Pain Education Programs for Inflammatory Bowel Disease
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
Through a pilot randomized controlled trial (RCT), we aim to test the feasibility and preliminary impact of two online pain educations programs among adult patients with inflammatory bowel disease (IBD) who experience chronic pain. Each online program can be accessed on the patient's personal device, and will take up to 2 hours to complete. Clinical outcomes (pain intensity, pain interference, quality of life) will be assessed via online surveys at baseline and then weekly for 8-weeks post-treatment.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 22 Jun 2026
- Start date
- Oct 2026
- Primary completion date
- Jul 2027
- Lead sponsor
- Cedars-Sinai Medical Center
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT07671313
What you commit to
- Study type: Interventional
- Planned participants: 60
- From Oct 2026 to the primary completion date, Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of standing opioid medications, given the often severe impact of opioids on GI motility and potential for pharmacological visceral hyperalgesia
- Prior participation in cognitive behavioral therapy (CBT) specifically targeting chronic IBD-related pain
Other illness
- Cognitive impairment or other condition that, in the opinion of the investigators, would interfere with protocol participation
- Taken any oral steroid medications for IBD or any other condition in the past 2 months (including prednisone, prednisolone, and methylprednisolone \[Medrol\])
Who the study is looking for
- Physician-confirmed diagnosis of Crohn's disease or ulcerative colitis
- Chronic pain (visceral and/or somatic) related to IBD for at least 3 months
- NIH PROMIS Pain Interference scale T-score ≥60
- Medically stable, defined as:
- No acute IBD-related hospitalization within the past 3 months; AND
- No planned IBD surgery or planned therapeutic escalation within the next 2 months, including initiation of a new advanced therapy, dose escalation or switch of advanced therapy, or corticosteroid taper
- Able to understand and complete questionnaires independently in English
- Access to an internet-enabled device for online surveys and intervention access.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cedars-Sinai Medical Center Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.